Kruse TA - Search Results

1

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.

Lecarpentier J, Silvestri V, Kuchenbaecker KB, Barrowdale D, Dennis J, McGuffog L, Soucy P, Leslie G, Rizzolo P, Navazio AS, Valentini V, Zelli V, Lee A, Amin Al Olama A, Tyrer JP, Southey M, John EM, Conner TA, Goldgar DE, Buys SS, Janavicius R, Steele L, Ding YC, Neuhausen SL, Hansen TVO, Osorio A, Weitzel JN, Toss A, Medici V, Cortesi L, Zanna I, Palli D, Radice P, Manoukian S, Peissel B, Azzollini J, Viel A, Cini G, Damante G, Tommasi S, Peterlongo P, Fostira F, Hamann U, Evans DG, Henderson A, Brewer C, Eccles D, Cook J, Ong KR, Walker L, Side LE, Porteous ME, Davidson R, Hodgson S, Frost D, Adlard J, Izatt L, Eeles R, Ellis S, Tischkowitz M; EMBRACE; Godwin AK, Meindl A, Gehrig A, Dworniczak B, Sutter C, Engel C, Niederacher D, Steinemann D, Hahnen E, Hauke J, Rhiem K, Kast K, Arnold N, Ditsch N, Wang-Gohrke S, Wappenschmidt B, Wand D, Lasset C, Stoppa-Lyonnet D, Belotti M, Damiola F, Barjhoux L, Mazoyer S; GEMO Study Collaborators; Van Heetvelde M, Poppe B, De Leeneer K, Claes KBM, de la Hoya M, Garcia-Barberan V, Caldes T, Perez Segura P, Kiiski JI, Aittomäki K, Khan S, Nevanlinna H, van Asperen CJ; HEBON; Vaszko T, Kasler M, Olah E, Balmaña J, Gutiérrez-Enríquez S, Diez O… See abstract for full author list ➔ Lecarpentier J, et al. Among authors: kruse ta. J Clin Oncol. 2017 Jul 10;35(20):2240-2250. doi: 10.1200/JCO.2016.69.4935. Epub 2017 Apr 27. J Clin Oncol. 2017. PMID: 28448241 Free PMC article.

2

Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation.

Thomassen M, Kruse TA, Olsen KE, Borg A, Gerdes AM. Thomassen M, et al. Among authors: kruse ta. Breast Cancer Res Treat. 2004 Oct;87(3):273-6. doi: 10.1007/s10549-004-9503-3. Breast Cancer Res Treat. 2004. PMID: 15528970

3

Evaluation of two different models to predict BRCA1 and BRCA2 mutations in a cohort of Danish hereditary breast and/or ovarian cancer families.

Gerdes AM, Cruger DG, Thomassen M, Kruse TA. Gerdes AM, et al. Among authors: kruse ta. Clin Genet. 2006 Feb;69(2):171-8. doi: 10.1111/j.1399-0004.2006.00568.x. Clin Genet. 2006. PMID: 16433698

4

A missense mutation in exon 13 in BRCA2, c.7235G>A, results in skipping of exon 13.

Thomassen M, Kruse TA, Jensen PK, Gerdes AM. Thomassen M, et al. Among authors: kruse ta. Genet Test. 2006 Summer;10(2):116-20. doi: 10.1089/gte.2006.10.116. Genet Test. 2006. PMID: 16792514

5

Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies.

Karppinen SM, Barkardottir RB, Backenhorn K, Sydenham T, Syrjäkoski K, Schleutker J, Ikonen T, Pylkäs K, Rapakko K, Erkko H, Johannesdottir G, Gerdes AM, Thomassen M, Agnarsson BA, Grip M, Kallioniemi A, Kere J, Aaltonen LA, Arason A, Møller P, Kruse TA, Borg A, Winqvist R. Karppinen SM, et al. Among authors: kruse ta. J Med Genet. 2006 Nov;43(11):856-62. doi: 10.1136/jmg.2006.041731. Epub 2006 Jul 6. J Med Genet. 2006. PMID: 16825437 Free PMC article.

6

Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark.

Thomassen M, Gerdes AM, Cruger D, Jensen PK, Kruse TA. Thomassen M, et al. Among authors: kruse ta. Cancer Genet Cytogenet. 2006 Jul 15;168(2):168-71. doi: 10.1016/j.cancergencyto.2005.12.016. Cancer Genet Cytogenet. 2006. PMID: 16843109

7

Comparison of gene sets for expression profiling: prediction of metastasis from low-malignant breast cancer.

Thomassen M, Tan Q, Eiriksdottir F, Bak M, Cold S, Kruse TA. Thomassen M, et al. Among authors: kruse ta. Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5355-60. doi: 10.1158/1078-0432.CCR-07-0249. Clin Cancer Res. 2007. PMID: 17875763 Free article.

8

Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis.

Thomassen M, Tan Q, Kruse TA. Thomassen M, et al. Among authors: kruse ta. Breast Cancer Res Treat. 2009 Jan;113(2):239-49. doi: 10.1007/s10549-008-9927-2. Epub 2008 Feb 22. Breast Cancer Res Treat. 2009. PMID: 18293085

9

BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.

Thomassen M, Hansen TV, Borg A, Lianee HT, Wikman F, Pedersen IS, Bisgaard ML, Nielsen FC, Kruse TA, Gerdes AM. Thomassen M, et al. Among authors: kruse ta. Acta Oncol. 2008;47(4):772-7. doi: 10.1080/02841860802004974. Acta Oncol. 2008. PMID: 18465347

10

Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer.

Thomassen M, Tan Q, Kruse TA. Thomassen M, et al. Among authors: kruse ta. BMC Cancer. 2008 Dec 30;8:394. doi: 10.1186/1471-2407-8-394. BMC Cancer. 2008. PMID: 19116006 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

349 results

Search Page